MYGN
Myriad Genetics Inc
NASDAQ: MYGN · HEALTHCARE · DIAGNOSTICS & RESEARCH
$4.11
-18.29% today
Updated 2026-05-06
Market cap
$475.05M
P/E ratio
—
P/S ratio
0.85x
EPS (TTM)
$-4.31
Dividend yield
—
52W range
$4 – $9
Volume
1.9M
Myriad Genetics Inc (MYGN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-28.03M | $-25.85M | $103.74M | $84.04M | $155.09M | $130.83M | $141.80M | $173.90M | $190.20M | $140.50M | $166.30M | $106.20M | $115.90M | $83.70M | $83.70M | $18.60M | $-106.30M | $-110.90M | $-8.70M | $1.80M |
| Capital expenditures | $7.68M | $11.40M | $13.68M | $7.53M | $7.89M | $5.79M | $10.16M | $11.40M | $14.30M | $23.90M | $5.00M | $6.10M | $8.40M | $8.60M | $8.60M | $18.00M | $45.30M | $73.30M | $29.70M | $27.40M |
| Depreciation | $6.86M | $7.54M | $8.78M | $9.45M | $7.08M | $7.22M | $9.07M | $8.90M | $13.80M | $25.00M | $26.80M | $48.30M | $54.40M | $73.00M | $73.00M | $62.80M | $52.70M | $61.90M | $61.20M | — |
| Stock-based comp | $-231000.00 | — | $15.41M | $25.68M | $22.78M | $25.09M | $26.27M | $26.60M | $27.10M | $45.70M | $31.60M | $29.90M | $27.10M | $33.50M | $33.50M | $36.30M | $38.10M | $40.70M | $49.80M | $35.20M |
| Free cash flow | $-35.71M | $-37.25M | $90.06M | $76.52M | $147.19M | $125.04M | $131.65M | $162.50M | $175.90M | $116.60M | $161.30M | $100.10M | $107.50M | $75.10M | $75.10M | $600000.00 | $-151.60M | $-184.20M | $-38.40M | $-25.60M |
| Investing cash flow | $-72.83M | $-46.74M | $-31.30M | $-206.34M | $-76.67M | $-54.39M | $-38.89M | $-74.90M | $-17.10M | $40.90M | $-91.40M | $-146.30M | $-11.60M | $-286.40M | $19.30M | $274.40M | $-77.50M | $31.90M | $-11.90M | — |
| Financing cash flow | $149.92M | $117.45M | $21.87M | $-51.92M | $-49.09M | $-116.60M | $-69.25M | $-80.60M | $-211.80M | $-177.30M | $-68.30M | $71.80M | $-95.00M | $182.30M | $182.30M | $-150.60M | $-8.00M | $152.90M | $-7.40M | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | $403.00M | — | $340.00M | $340.00M | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $70.50M | — | — | — | — | — |